Rapid Progression of Anemia Related to Tumor-lysis Syndrome Associated with Bortezomib Treatment in Myeloma Patients.
Suzuki K et al. Jpn J Clin Oncol. 2014 Mar 23. [Epub ahead of print].
Prediction of presence of kidney disease in a general patient population undergoing intravenous iodinated contrast enhanced computed tomography.
Moos SI et al. Eur Radiol. 2014 Mar 25. [Epub ahead of print].
Rare pancreas tumor mimicking adenocarcinoma: Extramedullary plasmacytoma.
Akyuz F et al. World J Gastrointest Endosc. 2014 Mar 16;6(3):99-100. doi: 10.4253/wjge.v6.i3.99.
A case of acute promyelocytic leukemia concomitant with plasma cell myeloma.
Lim J et al. Ann Lab Med. 2014 Mar;34(2):152-4. doi: 10.3343/alm.2014.34.2.152. Epub 2014 Feb 13.
Dialysis-dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myeloma.
Murphy PT et al. Br J Haematol. 2014 Mar 5. doi: 10.1111/bjh.12818. [Epub ahead of print].
Dialysis-dependent renal failure at diagnosis continues to be associated with very poor outcome in multiple myeloma – response to Murphy et al.
Pozzi S et al. Br J Haematol. 2014 Mar 6. doi: 10.1111/bjh.12816. [Epub ahead of print].
Venous Thromboembolism in Multiple Myeloma.
Stefano VD et al. Semin Thromb Hemost. 2014 Mar 5. [Epub ahead of print].
Assessment of bortezomib induced peripheral neuropathy in multiple myeloma by the reduced Total Neuropathy Score.
Zaroulis CK et al. Leuk Lymphoma. 2014 Mar 19. [Epub ahead of print].